The Venture Codex Logo

The Venture Codex

JITO Angel Network

A-201, Solitaire Park, Business Square, Chakala, Andheri East, Maharashtra, 400093, India

Overview

JITO Angel Network is backed by JITO's 15000+ Industrialits, Businessmen and HNI's of the Jain community spread worldwide. They provide Business support that accelerates the growth of startups.

Total investments
41
Lead investments
15
Investments · 12mo
2
Active investors
2

Sector focus

  • Non Profit
Visit website

Investment portfolio

  • the EleFant

    Participated · Series A · May 2026

    The EleFant operates a toy-subscription and circular play platform for children aged 0–12, offering more than 1,000 toys and books from over 90 brands. Families subscribe through monthly plans starting at Rs 599 and can return toys after use and select new ones through the platform. The company uses a Franchise-Invested, Company-Operated (FICO) model and has over 125 franchise partners across 18 cities. Founded by Sourabh Jain and Srishti Jain, The EleFant has set goals to cross 50,000 subscribers and expand into more than 20 cities within the next 12 months. Following its recent $1 million pre-Series raise, the startup plans to use proceeds to strengthen technology infrastructure and expand its market presence.

  • immunitoAI

    Participated · Series A · Nov 2025

    Founded in November 2020 by Aridni Shah and Trisha Chatterjee in Bengaluru, immunitoAI operates at the intersection of biotechnology and AI. Its core product is a generative AI platform that creates entirely new antibody sequences for any target antigen, shrinking discovery timelines from four–five years to roughly 11–12 months. The company maintains an in-house wet lab to validate and test the computer-generated antibodies. immunitoAI plans to earn revenue through three channels: selling proprietary antibody IP, undertaking custom antibody development projects for pharmaceutical clients, and eventually offering end-to-end drug development as a fully integrated pharma company. The startup is currently pre-revenue, but management projects that a single custom-developed antibody could fetch about USD 300 million plus royalties. By reducing discovery costs and timelines by more than 50%, the platform aims to accelerate targeted therapies for diseases such as cancer and autoimmune disorders. The newly raised capital will fund the development of trial-ready antibodies for specific diseases, advancing the company toward commercialization.

  • MangoPoint

    Participated · Series A · Aug 2025

    MangoPoint is a Chennai-based agritech exporter of chemical-free, single-origin Indian mangoes and processed mango products. The company primarily serves North America and Europe and holds FDA clearance for exports to key international markets. It operates APEDA and NPPO-recognized packhouses to support its supply chain. MangoPoint currently handles over 2,000 metric tonnes of mangoes annually and plans to scale this tenfold to 20,000 MT in the coming years. The startup plans to use fresh funding to scale infrastructure, expand into new markets, strengthen backend operations, and diversify product offerings. Market research cited in the article values the global mango industry at $60 billion, with India contributing $20 billion and growing at an estimated 4.9%–8% CAGR. Founded in 2018 by Manjula Gandhi Rooban and Prasanna Venkatarathnam, MangoPoint operates the first APEDA- and NPPO-recognized packhouse in Tamil Nadu. The company exports single-origin, carbide-free, chemical-free fresh mangoes and processed mango products to Europe and North America. MangoPoint emphasizes a sustainable integrated value chain, including eco-friendly farming, planet-friendly processing, and sustainable packaging. The business has already added two more farm-gate infrastructures focused on mango and plans further expansion of farm-gate capacity. The recent INR 3.5 Crore investment will be used to expand farmgate infrastructures, enhance scalability, and accelerate growth. MangoPoint positions itself to increase farmer incomes by promoting natural ripening and improved mango-growing practices.

  • Darwix AI

    Led · Seed · Jun 2025

    Darwix AI (CUR8 Ventures Pvt. Ltd.) offers an omnichannel generative AI platform, Transform+, powered by a proprietary LLM stack to provide conversational intelligence to enterprises. The platform delivers real-time agent assistance, automation and actionable insights across voice, chat, email and in-person interactions. Darwix targets enterprise verticals including BFSI and retail and operates across the US, India and the Middle East. Founded by Ajay Sethi and Hanit Awal, the company is focused on unifying and enhancing customer interactions through its AI solutions. The firm plans to deploy recent funding toward product development, market expansion, team growth and scaling its omnichannel platform.

  • Zintlr

    Participated · Seed · Oct 2024

    Zintlr offers an AI-powered buyer intelligence platform with a curated contact database, revenue insights, and market-specific prospects. The product includes personality insights to help tailor pitches, anticipate objections, and build stronger customer relationships. Its tools are aimed at large corporations and MNCs to shorten sales cycles, boost conversions, and close more deals. Founded in 2022 by Ravi Jain, Ujwal Kumar, and Pranay Khariwal, the company focuses on B2B intelligence for markets like India. Zintlr plans to use new funding to scale its team, expand market reach, and develop new product verticals. The company recently completed a seed fundraise that updates its early-stage financial position.

Team